positive quarterly report, page-13

To just labour a point:
On 25th June eBioscience was acquired by Affymetrix, Inc a company that develops, manufactures and sells products and services for genetic analysis to the life science research and clinical healthcare markets. Included in the Affymetrix product range are many assays for which Mix&Go is likely to demonstrate benefit. Discussions surrounding these issues are currently in train. In consequence it is expected that the Affymerix acquisition of eBioscience will provide revenue opportunities beyond those originally anticipated by Anteo. We expect these revenues opportunities to become increasingly apparent through the course of the current financial year.

Therefore we do a deal with one company.
It is already apparent that mix n go is being expanded thru their applications.
Then that company is taken over by another company which expands the applications into another company.

In some respects I feel the market has overlooked the fact that this is like another signing.

Just my 2 bob's worth ... (hopefully to at least bring the share price near term up to two bob....and then beyond!!!)